Louise C. Druedahl

Phone+4535337424
EmailLouise.Druedahljur.kudk
Websitehttps://jura.ku.dk/cebil/, http://jura.ku.dk/cebil/

Karen Blixens Plads 16, 2300 København S, 6B Bygning 6B, 6B-3-04

Research activity per year

Short presentation

I work as a PostDoc in the intersection between Law and Science at CeBIL (https://jura.ku.dk/cebil/)

Current research

I am currently investigating the regulatory and legal aspects of medical devices that uses artificial intelligence to in real-time support surgeons when they operate colon cancer.

See more about the CLASSICA project:
https://jura.ku.dk/cebil/research/classica/

Twitter: https://twitter.com/LCDruedahl

LinkedIn: https://www.linkedin.com/in/louisedruedahl/

Research interests

So far my research interests have focused on the topics of:

Use of artificial intelligence for drugs and medical devices
R&D innovation of COVID-19 vaccines
Biologics
Manufacturing of biologics
Biosimilars from regulator, industry, clinician and patient perspectives
Patient attitudes to and experiences with taking ADHD medication as well as astma medicine
Use of antibiotics in countries of the Eastern WHO European region.
The pharmacy profession

I have worked with and am interested in:

Qualitative research
Quantitative research
Interdisciplinary research and collaborations
Sociological theories (e.g. Foucault, Medicalization/Pharmaceuticalization)

CV

I have a PhD in Regulatory Science and hold a MSc in Pharmacy.

Education/Academic qualification

PhD

Award Date: 27 Feb 2021

Pharmacist (MScPharm/PharmD)

Award Date: 14 Oct 2016

133 Citations
17 Journal article
6 Conference abstract for conference
3 Book chapter
3 Conference abstract in journal

Patient perspectives on data sharing
Druedahl, L. C. & Kälvemark Sporrong, S., 2024, he Law and Ethics of Data Sharing in Health Sciences: Perspectives in Law, Business and Innovation. Singapore: Springer, p. 51-67
Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research › peer-review

Open Access
File

1 Citation (Scopus)

9 Downloads (Pure)
Use of Artificial Intelligence in Drug Development: A Cross-Sectional Study
Druedahl, L. C., Price II, W. N., Minssen, T. & Sarpatwari, A., 2024, In: JAMA network open. 7, 5, 4 p., e2414139.
Research output: Contribution to journal › Journal article › Research › peer-review

Open Access

1 Citation (Scopus)
Assessing change of traditions: teachers’ insights on a legal education under transformation
Druedahl, L. C., 2023, In: European Journal of Legal Education. 4, 1, p. 161-177 17 p.
Research output: Contribution to journal › Journal article › Research › peer-review

Open Access
File
Clinical evidence and use of extrapolation in European biosimilar marketing authorizations
Druedahl, L. C., Vive Nielsen, C. & Hallgreen, C. E., 2023, (In preparation) In: BioDrugs.
Research output: Contribution to journal › Journal article › Research › peer-review
Evidence-based IP research
Aboy, M., Druedahl, L. C. & Minssen, T., 2023, Research Handbook on Empirical Studies in Intellectual Property Law. Derclaye, E. (ed.). London: Edward Elgar Publishing, p. 120-136
Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research › peer-review

File
‘The way you talk, do I have a choice?’: Patient narratives of medication decision-making during hospitalization
Rognan, S. E., Jørgensen, M. J., Mathiesen, L., Druedahl, L. C., Lie, H. B., Bengtsson, K., Andersson, Y. & Sporrong, S. K., 2023, In: International Journal of Qualitative Studies on Health and Well-Being. 18, 1, 15 p., 2250084.
Research output: Contribution to journal › Journal article › Research › peer-review

Open Access
File

3 Citations (Scopus)

17 Downloads (Pure)
"Biosimilar, so it looks alike, but what does it mean?" A qualitative study of Danish patients' perceptions of biosimilars
Varma, M., Almarsdóttir, A. B. & Druedahl, L. C., 2022, In: Basic & Clinical Pharmacology & Toxicology. 130, 5, p. 581-591
Research output: Contribution to journal › Journal article › Research › peer-review

Open Access
File

11 Citations (Scopus)

45 Downloads (Pure)
Challenges in qualitative social pharmacy research: Reflections based on a conference workshop
Kälvemark Sporrong, S., Kaae, S., Nørgaard, L. S., Møllebæk, M., Waaseth, M., Cantarero Arevalo, L., Persson, C. L., Bekker, C. L., Lindell, J. F. & Druedahl, L. C., 2022, In: Research in Social and Administrative Pharmacy. 18, 1, p. 2254-2258
Research output: Contribution to journal › Journal article › Research › peer-review

1 Citation (Scopus)

9 Organisation of and participation in conference
4 Lecture and oral contribution
3 Participation in workshop, seminar, course

Accelerating Pharmaceutical Science: innovating and collaborating to fight COVID-19 and future pandemics
Louise C. Druedahl (Invited speaker)
5 Dec 2022
Activity: Talk or presentation types › Lecture and oral contribution
Legal, Ethical and Liability Issues
Marcelo Corrales Compagnucci (Speaker) & Louise C. Druedahl (Speaker)
15 Nov 2022
Activity: Talk or presentation types › Lecture and oral contribution
Responsible Machine Learning in Health: Regulatory and Legal Aspects
Louise C. Druedahl (Invited speaker)
27 Oct 2022 → 28 Oct 2022
Activity: Talk or presentation types › Lecture and oral contribution
ITU/WHO Workshop on “AI for Health”
Louise C. Druedahl (Invited speaker) & Timo Minssen (Invited speaker)
19 Sep 2022
Activity: Talk or presentation types › Lecture and oral contribution
New Horizons of Digital Nanomedicine and ELSI
Louise C. Druedahl (Invited speaker) & Timo Minssen (Invited speaker)
22 Aug 2022
Activity: Participating in an event - types › Organisation of and participation in conference
Kick-off Meeting of the CLASSICA project
Marcelo Corrales Compagnucci (Speaker), Timo Minssen (Speaker), Louise C. Druedahl (Participant) & Sara Gerke (Speaker)
9 May 2022 → 10 May 2022
Activity: Participating in an event - types › Participation in workshop, seminar, course
The Legal Dimensions of Quantum Computing
Timo Minssen (Invited speaker) & Louise C. Druedahl (Invited speaker)
29 Apr 2022
Activity: Participating in an event - types › Organisation of and participation in conference
DIA Europe 2022
Louise C. Druedahl (Invited speaker)
30 Mar 2022
Activity: Participating in an event - types › Organisation of and participation in conference

Vild vækst i hovedstadens medicinalbranche: Over 10.000 nye jobs på fem år (nyhedsindslag og artikel)
Louise C. Druedahl
23/09/2022 → 26/09/2022
2 Media contributions
Press/Media: Press / Media
Patienters bekymringer om biosimilær medicin
Louise C. Druedahl, Meera Varma & Anna Birna Almarsdóttir
01/09/2022
1 Media contribution
Press/Media: Press / Media
Patient perspectives on biosimilars in a high uptake country
Louise C. Druedahl
27/05/2022
1 Media contribution
Press/Media: Press / Media
Forsker: Her er udfordringerne for biosimilære lægemidlers udskiftelighed
Louise C. Druedahl
16/03/2022
1 Media contribution
Press/Media: Press / Media
Will the unclear path of biosimilar interchangeability become clearer?
Louise C. Druedahl
11/03/2022
1 Media contribution
Press/Media: Press / Media
On the edge of transition: European biosimilar clinical trial requirements
Louise C. Druedahl
31/05/2021
1 Media contribution
Press/Media: Press / Media
Forsker: Jura står i vejen for biosimilært potentiale
Louise C. Druedahl
19/03/2021
1 Media contribution
Press/Media: Press / Media
Scientific, legal and regulatory challenges facing biosimilars development
Louise C. Druedahl
11/12/2020
1 Media contribution
Press/Media: Press / Media

EliteResearch Travel Grant 2020
Druedahl, Louise C. (Recipient), 2020
Prize: Prizes, scholarships, distinctions

Louise C. Druedahl

Personal profile

Short presentation

Current research

CV

Education/Academic qualification

Collaborations and top research areas from the last five years

Dive into details

Patient perspectives on data sharing

Use of Artificial Intelligence in Drug Development: A Cross-Sectional Study

Assessing change of traditions: teachers’ insights on a legal education under transformation

Clinical evidence and use of extrapolation in European biosimilar marketing authorizations

Evidence-based IP research

‘The way you talk, do I have a choice?’: Patient narratives of medication decision-making during hospitalization

"Biosimilar, so it looks alike, but what does it mean?" A qualitative study of Danish patients' perceptions of biosimilars

Challenges in qualitative social pharmacy research: Reflections based on a conference workshop

Accelerating Pharmaceutical Science: innovating and collaborating to fight COVID-19 and future pandemics

Legal, Ethical and Liability Issues

Responsible Machine Learning in Health: Regulatory and Legal Aspects

ITU/WHO Workshop on “AI for Health”

New Horizons of Digital Nanomedicine and ELSI

Kick-off Meeting of the CLASSICA project

The Legal Dimensions of Quantum Computing

DIA Europe 2022

Vild vækst i hovedstadens medicinalbranche: Over 10.000 nye jobs på fem år (nyhedsindslag og artikel)

Patienters bekymringer om biosimilær medicin

Patient perspectives on biosimilars in a high uptake country

Forsker: Her er udfordringerne for biosimilære lægemidlers udskiftelighed

Will the unclear path of biosimilar interchangeability become clearer?

On the edge of transition: European biosimilar clinical trial requirements

Forsker: Jura står i vejen for biosimilært potentiale

Scientific, legal and regulatory challenges facing biosimilars development

EliteResearch Travel Grant 2020

Louise C. Druedahl

Personal profile

Short presentation

Current research

CV

Education/Academic qualification

Collaborations and top research areas from the last five years

Research output

Activities

Press/Media

Prizes